17 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
commitment basis. We have granted the underwriter an option to buy up to an additional 985,714 shares of common stock from us to cover over-allotments
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
of the compensation payable to the underwriter.
This offering is being underwritten on a firm commitment basis. We have granted the underwriter an option
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
in one or more underwritten offerings in a best efforts basis or firm commitment basis;
broker-dealers may agree with the Selling Stockholders to sell
DEF 14A
sob0b
25 Apr 22
Definitive proxy
5:28pm
8-K
EX-3.2
ty4prt0 s2j3nsfz
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
S-1/A
EX-10.23
aainid9mhtwmd8zesh
29 Jul 21
IPO registration (amended)
4:45pm
S-1/A
EX-10.24
grykf1xffj28
29 Jul 21
IPO registration (amended)
4:45pm
S-1/A
EX-3.8
ejssplajqfj5 x0
29 Jul 21
IPO registration (amended)
4:45pm
S-1
EX-10.6
tr14hd jmc9
19 Jul 21
IPO registration
7:02am
- Prev
- 1
- Next